BS ISO 11249:2026

This standard BS ISO 11249:2026 Copper-bearing intrauterine contraceptive devices. Guidance on the design, execution, analysis and interpretation of clinical studies is classified in these ICS categories:

• 11.200 Birth control. Mechanical contraceptives

BS ISO 11249:2026 - Copper-bearing Intrauterine Contraceptive Devices

Standard Number: BS ISO 11249:2026

Pages: 32

Release Date: 18th May 2026

ISBN: 978 0 539 37065 2

Status: Standard

Overview

The BS ISO 11249:2026 standard provides comprehensive guidance on the design, execution, analysis, and interpretation of clinical studies specifically for copper-bearing intrauterine contraceptive devices (IUDs). This standard is an essential resource for researchers, healthcare professionals, and manufacturers involved in the development and evaluation of these contraceptive devices.

Purpose and Importance

Intrauterine contraceptive devices are a critical component of reproductive health, offering a reliable and long-term method of contraception. The copper-bearing IUDs, in particular, are known for their effectiveness and safety. The BS ISO 11249:2026 standard aims to ensure that clinical studies conducted on these devices are thorough, scientifically sound, and adhere to international best practices.

Key Features

• Comprehensive Guidance: The standard provides detailed instructions on how to design and conduct clinical studies, ensuring that all relevant factors are considered and addressed.
• Scientific Rigor: Emphasizes the importance of scientific rigor in the execution of clinical trials, ensuring that results are reliable and valid.
• Data Analysis: Offers guidance on the appropriate methods for analyzing clinical data, helping researchers draw accurate and meaningful conclusions.
• Interpretation of Results: Provides insights into the interpretation of study results, facilitating informed decision-making in the development and approval of copper-bearing IUDs.

Who Should Use This Standard?

This standard is invaluable for a wide range of stakeholders in the field of reproductive health and contraceptive technology, including:

• Researchers: Those conducting clinical studies on copper-bearing IUDs will find this standard an indispensable guide to ensuring their research meets international standards.
• Healthcare Professionals: Medical practitioners involved in the prescription and management of IUDs can benefit from understanding the rigorous testing and evaluation these devices undergo.
• Manufacturers: Companies involved in the production of copper-bearing IUDs can use this standard to guide the development and testing of their products, ensuring compliance with international norms.
• Regulatory Bodies: Organizations responsible for the approval and regulation of medical devices will find this standard useful in assessing the quality and safety of copper-bearing IUDs.

Benefits of Compliance

Adhering to the BS ISO 11249:2026 standard offers numerous benefits, including:

• Enhanced Credibility: Compliance with international standards enhances the credibility of clinical studies and the devices being tested.
• Improved Safety and Efficacy: Ensures that copper-bearing IUDs are safe and effective for users, reducing the risk of adverse effects.
• Global Recognition: Facilitates international recognition and acceptance of clinical study results, aiding in the global distribution and use of copper-bearing IUDs.
• Streamlined Approval Processes: Helps streamline the regulatory approval process by providing clear and standardized guidelines for clinical studies.

Conclusion

The BS ISO 11249:2026 standard is a vital tool for ensuring the quality and reliability of clinical studies on copper-bearing intrauterine contraceptive devices. By providing detailed guidance on the design, execution, analysis, and interpretation of these studies, it supports the development of safe and effective contraceptive options for women worldwide. Whether you are a researcher, healthcare professional, manufacturer, or regulator, this standard is an essential resource for advancing reproductive health technology.